Cephalosporin therapy in intraabdominal infection: comparative studies of cefotetan, latamoxef and cefoxitin.
Wilson
S E
SE
Harbour/UCLA Medical Centre, Department of Surgery University of California, Los Angeles, CA, USA.
D015746:Abdominal Pain / Q000209:etiology* / Q000382:microbiology; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects / Q000302:isolation & purification; D001424:Bacterial Infections / Q000188:drug therapy*; D015313:Cefotetan / Q000009:adverse effects / Q000627:therapeutic use*; D002440:Cefoxitin / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D008826:Microbial Sensitivity Tests; D009070:Moxalactam / Q000009:adverse effects / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D015313:Cefotetan; D002440:Cefoxitin; D009070:Moxalactam